Overview

Open Label Crossover Study Pharmacokinetics (PK) Study in Healthy Volunteers Receiving Various Forms of Fentanyl

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
A partially randomized, open-label, 3-way crossover, single-center, systemic and CSF PK and bioavailability study in healthy volunteers.
Phase:
Phase 4
Details
Lead Sponsor:
Depomed
Treatments:
Fentanyl